This Act establishes a federal right to access fertility treatments, like IVF, based on widely accepted medical standards and preempts state laws that create unnecessary roadblocks or interfere with patient and provider choices.
Tammy Duckworth
Senator
IL
The Protect IVF Act establishes a federal right to access fertility treatments, such as IVF, based on widely accepted medical standards. It prohibits states from enacting or enforcing rules that create unnecessary roadblocks or conflict with these established medical practices. The law empowers individuals, providers, and insurers to sue to strike down restrictive state laws that interfere with evidence-based fertility care. Ultimately, this Act ensures that decisions regarding fertility treatment remain between patients and their doctors, overriding conflicting state regulations.
The newly introduced Protect IVF Act is a federal effort to shield access to fertility treatments, like in vitro fertilization (IVF), from state-level restrictions. Simply put, this bill establishes a national floor for fertility care, making sure that if a treatment meets widely accepted medical standards, states cannot pass laws that block, restrict, or unnecessarily complicate access to it.
This isn't just about protecting IVF procedures; the bill covers the whole spectrum of fertility care. This includes egg, sperm, and embryo freezing, assisted insemination (IUI), genetic testing on embryos, and all the necessary medications and gamete donation services. The core requirement for all these services is that they must align with "widely accepted and evidence-based medical standards of care," which the bill defines specifically as the guidelines set by the American Society for Reproductive Medicine (ASRM).
For individuals seeking care, the bill establishes several key rights. First, you have the right to receive fertility treatment from a provider, as long as it adheres to those ASRM-backed medical standards. This is a big deal because it means states can’t force you to undergo medically unnecessary tests or require extra, pointless in-person visits just to access care, as specified in Section 4(d)(1). If you’ve started a treatment plan, you have the right to finish it, even if a state tries to change the rules mid-way.
Perhaps the most critical protection for patients is the right to make decisions about their reproductive genetic material—meaning eggs, sperm, and embryos. You get to decide how those materials are donated, used, stored, or disposed of, and you can enter into contracts with providers about handling them. This provision directly addresses concerns that state laws might interfere with the current practice of cryopreserving embryos or restrict the number of eggs retrieved, which are standard components of modern IVF protocols.
For healthcare providers and manufacturers, the bill grants the right to offer these treatments, make fertility drugs, and distribute devices, again, provided they stick to the accepted medical standards. The catch here is that if a state passes a law that clashes with these new federal rights, the federal law wins. This is called preemption (Section 5), and it means state rules that are more restrictive than the ASRM guidelines are null and void.
For example, if a state tried to pass a law limiting the number of eggs a doctor could retrieve or requiring a specific, non-standard waiting period for embryo transfer—actions the medical community doesn't support—this federal law would block that state rule from being enforced. The only state laws that survive are those that specifically deal with resolving disputes between two people who both have rights to genetic material, or state laws that actively protect access to fertility care.
This bill doesn't just set rules; it gives people the power to enforce them. If a state actor (like a state regulator or attorney general) tries to enforce a rule that violates these new federal rights, the U.S. Attorney General can sue the state. More importantly for everyday folks, any individual or entity harmed by that restrictive state rule—the patient, the provider, or even the insurance company—can sue the state actor directly in federal court (Section 4(c)).
If you win that lawsuit, the court must make the state pay for your legal costs, including attorney's fees. This is a significant enforcement mechanism designed to make states think twice before passing laws that contradict widely accepted medical practices. It essentially creates a fast track to challenge state restrictions, allowing cases to bypass lengthy state administrative processes and go straight to federal court.
While the goal is to protect access, the framework relies entirely on the ASRM guidelines to define what constitutes the "widely accepted" standard of care. This is generally a good thing, as it puts medical decisions in the hands of medical experts, but it also means that states lose the ability to impose any stricter safety or facility regulations unless those regulations align perfectly with the ASRM standard. For busy people, this means less regulatory red tape and more consistent access to care, regardless of which state you live in, but it also means that the definition of "safe and effective" fertility treatment is centralized under one organization's guidance.